Log-in
Sign-up
Webcast
Clinical Trials
Webcast
Clinical Trials
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
TERMINATED
NCT05097599
StrataPATH™ (Precision Indications for Approved Therapies)
11
Enrollment(s)
4
Study location(s)
INTERVENTIONAL (PHASE2)
Cancer
Advanced Solid Tumor
ACTIVE_NOT_RECRUITING
NCT04784715
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
1,157
Enrollment(s)
284
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer; HER2-positive; Metastatic
COMPLETED
NCT04747496
Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China
5,000
Enrollment(s)
97
Study location(s)
OBSERVATIONAL (None)
Non-valvular Atrial Fibrillation
ACTIVE_NOT_RECRUITING
NCT04739761
A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer
506
Enrollment(s)
81
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04703322
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan
9
Enrollment(s)
6
Study location(s)
INTERVENTIONAL (PHASE2)
Tenosynovial Giant Cell Tumor
ACTIVE_NOT_RECRUITING
NCT04618913
Anticoagulation in Patients With Venous Thromboembolism and Cancer
1
Enrollment(s)
1
Study location(s)
OBSERVATIONAL (None)
Neoplasms
Embolism
ACTIVE_NOT_RECRUITING
NCT04556773
A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast Cancer
138
Enrollment(s)
37
Study location(s)
INTERVENTIONAL (PHASE1)
Metastatic Breast Cancer
ACTIVE_NOT_RECRUITING
NCT04538742
A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast Cancer
245
Enrollment(s)
72
Study location(s)
INTERVENTIONAL (PHASE1|||PHASE2)
Metastatic Breast Cancer
11
12
13
14
15